You don’t have any Active Subscription.

Subscribed with another email? Logout and Login with that one.

Your active subscription(s)

Account subscription benefits alongside Premium Stories, Editorials, Opinions and more. Unlock these with Subscription

Products you've access to

Additional Subscription Benefits

Need help with your subscription?

Updated - October 31, 2026 09:13 am IST - Mumbai

Bollywood actor Ajay Devgn. Photo: Special Arrangemnets

Bollywood actor Ajay Devgn has moved the Bombay High Court, challenging a show-cause notice issued by the Maharashtra Food and Drug Administration over his appearance in 'Vimal Elaichi' advertisements, calling the agency's action arbitrary.

A division bench of Chief Justice Mahesh Chandra Tripathi and Justice Advait Sethna is likely to hear Devgn’s petition on November 4.

As per the notice issued by the FDA to Devgn, the advertisements for 'Vimal Elaichi' amount to surrogate promotion of 'Vimal Pan Masala', a chewable product banned in Maharashtra.

Similar notices were issued to actors Shah Rukh Khan and Tiger Shroff, who had also appeared in the advertisements.

Devgn's petition stated that the notice was arbitrarily issued to him as an actor rather than to the manufacturing company.

FDA Commissioner Tukaram Mundhe on Friday (October 30, 2026) said that proceedings against Khan, Devgn and Shroff for allegedly violating State rules were complete.

The department had concluded its investigation and found violations by the actors, he said, adding that the matter will be referred for adjudication next week.

While Devgn has approached the High Court, the department would continue its proceedings before the joint commissioner, Mr. Mundhe said.

The FDA had earlier claimed that the 'Vimal Elaichi' campaign amounted to surrogate advertising for prohibited pan masala products.

The brand was linked to the sale of gutkha and pan masala, products prohibited in Maharashtra, it had alleged.

Published - October 31, 2026 09:11 am IST

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.